Mass meeting

General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90 (previous year: CHF 0.90)

Retrieved on: 
Wednesday, April 10, 2024
CHF, Compensated emancipation, Nomination, Mass meeting, Holding company

General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90 (previous year: CHF 0.90)

Key Points: 
  • General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90 (previous year: CHF 0.90)
    At today’s mobilezone holding ltd General Meeting, 49.9 percent of the share capital, or 65.0 percent of registered shares with voting rights, were represented.
  • The shareholders voted in favour of all the proposals from the Board of Directors.
  • Among other things, the following was approved:
    Payout of a dividend of CHF 0.90 per share on April 12, 2024 (ex-date April 10, 2024)
    At the constituent meeting of the Board of Directors, Lea Sonderegger was appointed Chairwoman of the Nomination & Compensation Committee.

RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024

Retrieved on: 
Wednesday, April 10, 2024
Notifiable disease, Euronext Growth, Mass meeting, Meeting, Therapy

RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024

Key Points: 
  • RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
    RESULTS OF THE COMBINED GENERAL MEETING ON APRIL 2, 2024
    Paris (France) and Cambridge (Massachusetts, USA), April 04, 2024 – 11:00pm CET – Biophytis SA (Nasdaq CM : BPTS, Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, announces the approval of all the resolutions presented by the Company and falling within the remit of the Ordinary and Extraordinary General Meeting.
  • Thanks to the mobilization of shareholders, the Meeting could be held with a quorum of almost 30% of the shareholders present or represented.
  • The resolutions, which notably included a renewal of the usual financial delegations granted to the Company, were all approved.
  • The results of the votes are available on the Biophytis website in the "Investors / General Meetings" section.

EQS-News: Alienation of own shares

Retrieved on: 
Wednesday, April 10, 2024
Annual, Exercise, Supervisory board, Disclosure, Internet, Raiffeisen Bank International, Sale, Mass meeting, Acquisition, Aktiengesellschaft, Publication, Joint-stock company, Commercial code, Security (finance)

Publication of the resolution of the Annual General Meeting of Raiffeisen Bank International AG in relation to the acquisition of own shares pursuant to sec.

Key Points: 
  • Publication of the resolution of the Annual General Meeting of Raiffeisen Bank International AG in relation to the acquisition of own shares pursuant to sec.
  • 1a and 1b of the Stock Corporation Act (AktG) as well as the alienation of own shares in a way other than by sale via the stock exchange or by public offer under exclusion of shareholders’ subscription right
    Publication pursuant to sec.
  • This authorization replaces the authorization to acquire and use own shares adopted at the General Meeting of 31 March 2022 in accordance with sec.
  • 1b of the Stock Corporation Act and with regard to the use of own shares also relates to the portfolio of own shares already acquired by the Company."

The Board of Directors comments on zCapital’s proposals

Retrieved on: 
Wednesday, April 10, 2024
Proxy, Risk, Form, Internet, Mass meeting, Insurance, QR, SMI Expanded, Orientation, Feedback, Security (finance)

Baloise’s Board of Directors encourages shareholders to vote and recommends zCapital’s proposals be rejected.

Key Points: 
  • Baloise’s Board of Directors encourages shareholders to vote and recommends zCapital’s proposals be rejected.
  • The Board offers the prospect to amend the corresponding provisions of the articles of association at the 2025 General Meeting.
  • On the 21st of February 2024, asset manager zCapital has submitted proposals to the Board of Directors, according to which the registration and voting rights restriction in the articles of associations is to be lifted.
  • In preparation for this statement, the Board of Directors has initiated the discussion with shareholders and other stakeholders.

Combined Shareholders’ Meeting to be Held on May 17, 2024: Availability of the Documents Relating to the 2024 Combined Shareholders’ Meeting

Retrieved on: 
Monday, April 8, 2024
EUR, Commercial code, Proxy, Insurance, Mass meeting, Bulletin, Combined

Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms.

Key Points: 
  • Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms.
  • Holders of registered shares will receive these forms with their convening notice.
  • The documents referred to in article R. 22-10-23 of the French Commercial Code are available on the Company’s website at www.scor.com under “Investors / Shareholders’ Meetings / Documents related to the 2024 General Meeting” or upon request from the Investor Relations department ( [email protected] ).
  • The Group generated premiums of EUR 19.4 billion in 2023 and serves clients in around 160 countries from its 35 offices worldwide.

Tritium Confirms Effective Date of Reverse Stock Split

Retrieved on: 
Thursday, March 28, 2024
Shareholder, Mass meeting, Consolidation

BRISBANE, Australia, March 28, 2024 (GLOBE NEWSWIRE) -- Tritium DCFC Limited (Nasdaq: DCFC) (“Tritium” or the “Company”), a global developer and manufacturer of direct current (“DC”) fast chargers for electric vehicles (“EVs”), today confirms the effective date of its reverse stock split.

Key Points: 
  • BRISBANE, Australia, March 28, 2024 (GLOBE NEWSWIRE) -- Tritium DCFC Limited (Nasdaq: DCFC) (“Tritium” or the “Company”), a global developer and manufacturer of direct current (“DC”) fast chargers for electric vehicles (“EVs”), today confirms the effective date of its reverse stock split.
  • As previously reported, on March 22, 2024, the Company held an Extraordinary General Meeting of Shareholders to consider the resolution to consolidate Company ordinary shares (the “Shares”) on the basis that every two-hundred (200) Shares be consolidated into one (1) Share (the “Consolidation”).
  • Following the completion of listing exchange procedures, the effective date of the Consolidation will be April 2, 2024.

Sword Group: Availability of preparatory documents for the Ordinary General Meeting of 29 April 2024

Retrieved on: 
Thursday, March 28, 2024
Single Form, Proxy, Shareholder, Annual, RESA, Mass meeting, Luxemburger Wort

The Ordinary General Meeting of Shareholders of Sword Group SE will be held at 11 a.m. on 29 April 2024.

Key Points: 
  • The Ordinary General Meeting of Shareholders of Sword Group SE will be held at 11 a.m. on 29 April 2024.
  • The notice of meeting including the agenda was published in the RESA (Recueil électronique des sociétés et associations) and in the Luxemburger Wort on 28 March 2024.
  • The terms and conditions for attending and voting at this meeting are set out in this notice.
  • Pending approval at the Annual General Meeting on April 29.

Sword Group: NOTICE OF CONVOCATION TO THE SHAREHOLDERS FOR THE ANNUAL ORDINARY GENERAL MEETING OF THE COMPANY

Retrieved on: 
Thursday, March 28, 2024
Remuneration, Approval, Proxy, Mass meeting, Policy, Bank statement, Confidentiality, Security (finance)

Shareholders have the right to ask questions regarding items on the agenda of the General Meeting.

Key Points: 
  • Shareholders have the right to ask questions regarding items on the agenda of the General Meeting.
  • The Ordinary General Meeting will validly deliberate on the agenda items if at least 25% of the issued share capital is present or represented.
  • The Extraordinary General Meeting will validly deliberate on the agenda items if at least 50% of the issued share capital is represented.
  • This notice shall serve as a notice of convocation unless any modifications are made to the agenda following requests for the inclusion of resolution proposals submitted by shareholders.

Notice of Annual General Meeting (AGM) of Bioretec Ltd

Retrieved on: 
Friday, April 5, 2024
Remuneration, Charter, Annual, EUR, Chair, PwC, Nomination, Exercise, Communication, Address, Travel, Mass meeting, Shareholder, Bank statement, Investment company, Annual general meeting, Tax, Companies Act, Chapter Five, Privacy, EET, Holding company

TAMPERE, Finland, April 5, 2024 /PRNewswire/ -- The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Tampere, Finland.

Key Points: 
  • A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation.
  • The authorization is valid until the end of the next Annual General Meeting, however, no longer than until 30 June 2025.
  • The Board of Directors proposes that the Annual General Meeting resolve to establish a shareholders' nomination board ("Nomination Board"), responsible for annually preparing and presenting to the Annual General Meeting and, if necessary, to an Extraordinary General Meeting, proposals on the composition (number of the members of the Board of Directors and the nominees) and remuneration of the Board of Directors.
  • The meeting minutes of the Annual General Meeting will be available on the company's website no later than 10 May 2024.

Notice of Annual General Meeting (AGM) of Bioretec Ltd

Retrieved on: 
Friday, April 5, 2024
Remuneration, Charter, Annual, EUR, Chair, PwC, Nomination, Exercise, Communication, Address, Travel, Mass meeting, Shareholder, Bank statement, Investment company, Annual general meeting, Tax, Companies Act, Chapter Five, Privacy, EET, Holding company

TAMPERE, Finland, April 5, 2024 /PRNewswire/ -- The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Tampere, Finland.

Key Points: 
  • A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation.
  • The authorization is valid until the end of the next Annual General Meeting, however, no longer than until 30 June 2025.
  • The Board of Directors proposes that the Annual General Meeting resolve to establish a shareholders' nomination board ("Nomination Board"), responsible for annually preparing and presenting to the Annual General Meeting and, if necessary, to an Extraordinary General Meeting, proposals on the composition (number of the members of the Board of Directors and the nominees) and remuneration of the Board of Directors.
  • The meeting minutes of the Annual General Meeting will be available on the company's website no later than 10 May 2024.